Icatibant acetate cas 138614-30-9
Acetate antagonista est receptae bradykinin B2, quod angioedema hereditarium tractari potest.
Icatibant(10-30μM)potentiatesangiotensinIII, sed notangiotensinII(contractionmediatedbyangiotensinAT1receChemicalbookptors), et Lys-des-Arg9-bradykinin, sed notdes-Arg9-bradykinin (effectis mediantibus dbythebradykininB1receptoribus).
Icatibant (10-30μM) potentiates angiotensin III, sed non angiotensinII (contractionmediatedbyangiotensinAT1receptores) et Lys-des-Arg9-bradykinin, sed notdes-Arg9-bradykinin (effectis mediantibus e. Exemplar animal: Mures feminei theCBA/J (H-Chemicalbook2k) contendunt.
Dosis: 0.06,0.3, or1.5mg/kg.
Administratio: Subcutaneous administrationtwicedaily.
Consequuntur: Longitudo maxima inewas93.6±6.8mm cum 1.5mg/kg dosage et 94.0±4.1mm cum 0.3mg/kg dosis, ostendens praecaventiam notabilem effectum minuendi.
Atebant acetatas possessiones at conditiones -20°C solubilitas DMSO:65.0(MaxConc.mg/mL); 47.63 (MaxConc. MM) Ethanol: 0.25 (MaxConc. mgChemicalbook/mL); 0.18 (MaxConc. MM) PBS (pH7.2) : 10.0 (MaxConc. Mg/mL); 7.33(MaxConc.mM) Acrystallinesolid
CAS numerus 138614-30-9
Formulae hypotheticae C59H89N19O13S.C2H4O2
Pondus hypotheticum 1364.59EINECS number: -
Proprietates physicae Altybantiae acetatis
Densitas 1.6g/cm3
Formulae hypotheticae C61H93N19O15S
pondus hypotheticum 1364,57000
Massa accurata 1363.68000
Icatibant acetate cas 138614-30-9
Acetate antagonista est receptae bradykinin B2, quod angioedema hereditarium tractari potest.
Anglicus alias
Seres alias